NCT03777488View on ClinicalTrials.gov

Pharmacokinetics of Tranexamic Acid After Oral, Intramuscular or Intravenous Administration: a Prospective, Randomised, Cross-over Trial in Healthy Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 30, 2019

Primary Completion Date

October 14, 2020

Study Completion Date

October 14, 2020

Conditions
Healthy Volunteer Study
Interventions
DRUG

Tranexamic Acid 1 gram intravenously

Intravenous tranexamic acid crossover to oral and intramuscular arms

DRUG

Tranexamic acid 2 grams oral solution

Oral tranexamic acid crossover to intravenous and intramuscular arms

DRUG

Tranexamic acid 1 gram intramuscular

Intramuscular tranexamic acid crossover to oral and intravenous arms

Trial Locations (2)

75743

Unité de Recherche Clinique Paris Descartes Necker Cochin, Hôpital Necker-Enfants Malades, Paris

78180

UFR Sciences de la Santé Simone Veil Université Versailles Saint Quentin en Yvelines, Montigny-le-Bretonneux

All Listed Sponsors
lead

London School of Hygiene and Tropical Medicine

OTHER

NCT03777488 - Pharmacokinetics of Tranexamic Acid After Oral, Intramuscular or Intravenous Administration: a Prospective, Randomised, Cross-over Trial in Healthy Volunteers. | Biotech Hunter | Biotech Hunter